CDK9 Inhibitors: A Promising Combination Partner in Treating Hematological Malignancies
August 9, 2023
PRESS RELEASE: On August 7, 2023, a new research perspective was published in Oncotarget, entitled, “CDK9 INHIBITORS: a promising combination partner in the treatment of hematological malignancies.” continue reading »